The MATRICS Consensus Cognitive Battery (MCCB) was developed to provide a reliable, valid, and standard battery for clinical trials on cognitive enhancers in schizophrenia. In this study we tested the applicability of the MCCB to Singapore’s English speakers. Healthy ethnic Chinese, Malay, and Indian English speakers (N = 171) of both genders were recruited within three age groups and three levels of education to match as closely as possible the US norming sample, and were administered the MCCB.

Rapisarda A, Lim T, Lim M, Collinson S, Kraus M, Keefe R. Applicability of the MATRICS Consensus Cognitive Battery in Singapore.  The Clinical Neuropsychologist, 2013; 27(3): 455-469.